Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 3/19/2025Teva and Kerry Form Strategic Partnership to Strengthen Pharma Supply ...
  • 3/19/2025Celregen Secures ~CNY 100M in Angel+ Financing
  • 3/19/2025Accropeutics Secured $12M in Series B Plus Financing
  • 3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...
  • 3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M
  • 3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
  • 3/13/2025Insilico Medicine Secures $110M, Explores IPO Amid AI Drug Discovery B...
  • 3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...
  • 3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...
  • 3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...
  • 3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...
  • 3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...
  • 3/10/2025Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx
  • 3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...
  • 3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  
  • 3/6/2025Bayer Expands Innovation in China with New E-Town Center
  • 3/4/2025Bioray's BR111: Pioneering Dual-Epitope ADC for ROR1-Positive Cancers
  • 3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
  • 3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...
  • 3/4/2025Raziel and Fosun's JuveStar Launch Phase 3 Trial in China for RZL-012
  • 2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China
  • 2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...
  • 2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...
  • 2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies
  • 2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...
  • 2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
  • 2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...
  • 2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief
  • 2/21/2025China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...
  • 2/21/2025FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal
  • Page:3/21 Total number of articles:607: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group